Blog

CNS Clinical Trials Are Prone To Duplicate Subjects and Duplicate Enrollment

CNS clinical trials, especially psychiatry clinical trials are prone to having duplicate subjects in clinical trials.  In studies that rely upon subjective end points, there exists the ability to provide false information in an effort to gain entry in to the study.  Of course, these occurrences result in failed trials due to elevated placebo rates

Read More »

Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials

Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads.  To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process.  VCT verifies a research subject’s study history at the time of

Read More »

Duplicate Subjects In Your Clinical Trials Result In Safety & Data Quality Issues

To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively.  This is true for nearly all therapeutic indications and all phases of clinical trials research.  Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue.  The global research subject database registry VCT data over the

Read More »

Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic

Read More »

Bad Behavior in Clinical Trials: Strategies to Combat Duplicate Subjects & Research Participant Dishonesty/Deception, Non-adherence, and “Professional Subjects

Join us at #ASCP2019 in Phoenix this year Wed. May 29th at 1 PM as VCT hosts an expert panel on professional research subjects and duplicate subjects in CNS clinical trials.  Duplicate subjects can ruin a trial, especially in the CNS space.  Without a research subject database registry like Verified Clinical Trials it is nearly impossible

Read More »